Riskpilot← Back to searchSign inGet full accessLinea Vitae Aktiebolag
ABActiveOrg 5565619128Ribbingsnäs StenholmenGeneral medical practice activities · NACE 8621Est. 19980 employees
Revenue 2025
SEK 0
EBITDA margin
—
-850% vs 2024
Equity ratio
70.9%
Financial strength
Net profit 2025
SEK -75K
-850% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -75K | -850% |
| Net profit | SEK -75K | -850% |
| Total assets | SEK 247K | -24% |
| Equity | SEK 175K | -30% |
| Employees | 0 | — |
Legal name
Linea Vitae Aktiebolag
Org number
5565619128
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
10 november 1998
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva husläkarverksamhet samt konsultation inom sjuk- och hälsovård och därmed förenlig verksamhet. Bolaget ska även bedriva litterär och musikalisk verksamhet, samt rådgivande verksamhet för såväl individer som grupper.
Address
Ribbingsnäs Stenholmen
Phone
+4638023128
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 40 | 72 | 112 | 111 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −86 | −49 | −16 | 10 | −75 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −86 | −49 | −16 | 10 | −75 |
| Net financials | — | — | — | — | — |
| Profit before tax | −86 | −49 | −16 | 10 | −75 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −86 | −49 | −16 | 10 | −75 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 379 | 330 | 314 | 324 | 247 |
| Equity | 305 | 255 | 240 | 250 | 175 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 74 | 74 | 74 | 74 | 72 |
| Total debt | 74 | 74 | 74 | 74 | 72 |
EBITDA margin
-7500000.0%
This company
15.8%
Market median
-47468454% vs market
20212025
Equity ratio
70.9%
This company
38.2%
Market median
+86% vs market
20212025
Return on equity
-42.9%
This company
18.4%
Market median
-333% vs market
20212025
Net profit margin
-7500000.0%
This company
8.1%
Market median
-92592693% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Linea Vitae Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Kristina Mörlid | Deputy Board Member | 0 companies |
| Lars Ebbe Nils Mörlid | Board of Directors | 0 companies |